Skip to content

Medical Device Innovators Use Panoplai For Winning Commercialization Strategy

nytw napkins-10-2

Industry

Healthcare

Challenge

ChestPal Pro—a smart stethoscope startup—had early traction in Europe but needed a winning commercialization strategy for the U.S. market. To succeed, they needed fast, credible insights from frontline healthcare providers—an audience that’s expensive and difficult to reach.

Results

ChestPal Pro unlocked new U.S. market opportunities and surfaced unexpected value propositions—giving leadership confidence to scale. With Panoplai, they now conduct high-impact research with hard-to-reach clinicians, extract insights instantly, and enrich studies by “recontacting” digital twins at any time, at a fraction of traditional costs.

“My daughter was 5 months old when she started coughing badly for weeks. I took her to a clinic multiple times, worried it could be something more serious. Thankfully, her lungs were clear...I thought there had to be a better way to check her lung health.”

Helena Binetskata

Founder & Chief Product Officer at ChestPal Pro

iStock-1550744419

About ChestPal Pro

ChestPal Pro is a smart stethoscope for lungs. It helps frontline healthcare providers to reliably detect lung crackles and wheezes—aiding diagnosis and patient management.

The Challenge

Helena realized that the stakes were extremely high. A more effective smart stethoscope could enhance clinical decision-making, catch more patient lung disorders before they became dangerous, and reduce unnecessary hospital and emergency room visits.

After a careful development and testing process, the product performed extremely well and the ChestPal Pro team started to achieve some initial successes across European markets.

The real prize, though, was the U.S. market. The path toward a winning commercialization strategy in the U.S. was still unclear.

The Solution

Conversing with the Panoplai team, they realized that employing AI-powered research would yield the balance of depth, nuance, scale, and speed they needed. Here's how:

 1. Panoplai was used to rapidly create an initial study design with a collection of open and close-ended questions.

 2. ChestPal Pro defined a precise mix of frontline providers as their target audience.

 3. Doctors and nurses engaged with Panoplai's intuitive chat-like interface to respond to a brief set of questions, express their emotions through emojis, and share their experiences and opinions in their own words.

 4. The Panoplai platform amazed the ChestPal Pro team by completing respondent recruitment and fielding the study in only three days.

The Results

The dashboard instantly analyzed open- and closed-ended responses alongside demographic data, uncovering new and unexpected use cases, market opportunities, and overwhelming enthusiasm for ChestPal Pro.

The ChestPal Pro team is harnessing Panoplai's AI and synthetic capabilities to engage with their data in dynamic, two-way conversations. With frontline medical providers being neither cheap nor easy to reach, they're maximizing every study's value.

They're using the platform to engage targeted audience segments, uncovering new opportunities through integrated data, analytics, and AI-driven consumer insights.

Beyond that, they're leveraging Panoplai to Enrich Data — asking follow-up questions to virtual extensions of their entire research sample. It's like a retargeting study, but in minutes and at a fraction of the cost.

About Panoplai

Panoplai is an AI-powered market research platform built for teams that need speed without sacrificing depth. We help content strategists, marketers, and product leaders uncover AI consumer insights, run advanced survey-based audience targeting, and build dynamic digital twin personas. From lead generation to content ops to product-market fit, Panoplai turns static data into fast, scalable intelligence. Want to see for yourself? Let's talk.

Want to read the full story?

Download the case study here